Jesús Novalbos
- Pharmacology top 2%
- Psychiatry and Mental health top 10%
- Molecular Biology
- Pharmacology top 10%
- Cardiology and Cardiovascular Medicine
- Co-authors
- Francisco Abad‐SantosRosario López‐RodríguezSonia Gallego‐SandínManuel RománDolores OchoaAntonio G. Garcı́aTeresa CabaleiroPedro Zapater
- Topics
- Pharmacogenetics and Drug Metabolism (15 papers)Schizophrenia research and treatment (7 papers)Neuroscience and Neuropharmacology Research (6 papers)
- Partner nations
- SpainUnited KingdomNetherlands
In The Last Decade
Jesús Novalbos
44 papers receiving 778 citations
Peers
Comparison fields: 5 of 94
- Pharmacology 217
- Psychiatry and Mental health 170
- Molecular Biology 162
- Pharmacology 125
- Cardiology and Cardiovascular Medicine 101
Countries citing papers authored by Jesús Novalbos
This map shows the geographic impact of Jesús Novalbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Novalbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Novalbos more than expected).
Fields of papers citing papers by Jesús Novalbos
This network shows the impact of papers produced by Jesús Novalbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Novalbos. The network helps show where Jesús Novalbos may publish in the future.
Co-authorship network of co-authors of Jesús Novalbos
This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Novalbos. A scholar is included among the top collaborators of Jesús Novalbos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Novalbos. Jesús Novalbos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 24 | |
| 6 | 44 | |
| 7 | 26 | |
| 8 | 11 | |
| 9 | 49 | |
| 10 | Peramivir. Un nuevo y potente inhibidor de la neuraminidasa para el tratamiento de las infecciones gripales | 2 |
| 11 | 20 | |
| 12 | 38 | |
| 13 | 13 | |
| 14 | 48 | |
| 15 | Estado actual de la citicolina en la isquemia cerebral | 3 |
| 16 | 1 | |
| 17 | 15 | |
| 18 | 51 | |
| 19 | 37 | |
| 20 | 37 |
About Jesús Novalbos
Jesús Novalbos is a scholar working on Pharmacology, Psychiatry and Mental health and Family Practice, having authored 47 papers that have together received 795 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Schizophrenia research and treatment (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). The work is most often cited by research in Pharmacology (217 citations), Psychiatry and Mental health (170 citations) and Pharmacology (125 citations). Jesús Novalbos has collaborated with scholars based in Spain, United Kingdom and Netherlands. Frequent co-authors include Francisco Abad‐Santos, Rosario López‐Rodríguez, Sonia Gallego‐Sandín, Manuel Román, Dolores Ochoa, Antonio G. Garcı́a, Teresa Cabaleiro, Pedro Zapater, Javier P. Gisbert and Μ. Borgers. Their work appears in journals such as Gastroenterology, International Journal of Molecular Sciences and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.